A Respiratory Therapist-Directed Protocol for Managing Inpatients with Asthma and COPD Incorporating a Long-Acting Bronchodilator

References

• Peters J I, Shelledy D C, Jones A P, Lawson R W, Davis C P, LeGrand T S. A randomized, placebo-controlled study to evaluate the role of salmeterol in the in-hospital management of asthma. Chest 2000; 118:313. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Ritz M, Thorens J R, Arnold-Ketterer M, Chevrolet J C. Effects of inhaled salmeterol and salbutamol (albuterol) on morning dips compared in intensive care unit patients recovering from an acute severe asthma attack. Intensive Care Med 1997; 23:1225. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Mahler D A, Donohue J F, Barbee R A, Goldman M D, Gross N J, Wisniewski M E, Yancey S W, Sakes B A, Richard K A, Anderson W H. Efficacy of salmeterol xinafoate in the treatment of COPD. Chest 1999; 115:957. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Pearlman D S, Chervinsky P, LaForge C, Seltzer J M, Southern D L, Kemp J P, Dockhorn R J, Grossman J, Liddle R F, Yancey S W, Cocchetto, Alexander W J, van As A. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. N Engl J Med 1992; 327:1420. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• D'Alonzo G E, Nathan R A, Henochowicz S, Morris R J, Ratner P, Rennard S I. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma. JAMA 1994; 271:1412. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• van Noord J A, Smeets J J, Raaijmakers J AM, Bommer A M, Maesen F PV. Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action. Eur Respir J 1996; 9:1684. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Moore R H, Khan A, Dickey B F. Long-acting inhaled β2-agonists in asthma therapy. Chest 1998; 113:1095. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Kips J C, Pauwels R A. Long-acting inhaled β2-agonist therapy in asthma. Am J Respir Crit Care Med 2001; 164:923. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Anderson G P. Formoterol: pharmacology, molecular basis of agonism, and mechanism of long duration of a highly potent and selective β2-adrenoceptor agonist bronchodilator. Life Sci 1993; 52:2145–2160. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Kollef M H, Shapiro S D, Clinkscale D, Crocchiolo L, Clayton D, Wilner R, Hossin L. The effect of respiratory therapist-initiated treatment protocols on patient outcomes and resource utilization. Chest 2000; 117:467. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Drummond M F, Stoddard G L, Torrance G W. Methods for the Economic Evaluation of Health Care Programmes. Oxford, England: Oxford Medical Publications, 1987.
   Google Scholar
• Stoller J K, Mascha E J, Kester L, Haney D. Randomized controlled trial of physician-directed versus respiratory therapy consult service-directed respiratory care to adult non-ICU inpatients. Am J Respir Crit Care Med 1998; 158:1068. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kesten S, Chapman K R, Broder I, Cartier A, Hyland R H, Knight A, Malo J L, Mazza J A, Moote D W, Small P, Tarlo S, Gontovnick L, Rebuck A S. A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma. Am Rev Respir Dis 1991; 144:622. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Schruers A JM, Damste H EJS, de Graaf C S, Greefhorst A PM. A dose-response study with formoterol Turbuhaler® as maintenance therapy in asthmatic patients. Eur Respir J 1996; 9:1678.
   PubMed Web of Science ®Google Scholar
• Bensch G, Lapidus R J, Levine B E, Lumry W, Yegen U, Kiselev P, Cioppa G D. A randomized, 12-week, double-blind, placebo-controlled study comparing formoterol dry powder inhaler with albuterol metered-dose inhaler. Ann Allergy Asthma & Immun 2001; 86:19. [CSA]
   PubMed Web of Science ®Google Scholar
• Fitzgerald J M, Chapman K R, Cioppa G D, Stubbing D, Fairbarn M S, Till M D, Brambilla R. Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. J Allergy Clin Immunol 1999; 103:427. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Hacki M, Hinz G W, Medici T C. Clinical experience over five years of daily therapy with formoterol in patients with bronchial asthma. Clin Drug Investig 1997; 14:165.
   Web of Science ®Google Scholar
• Nightingale J A, Rogers D F, Barnes P J. Comparison of the effects of salmeterol and formoterol in patients with severe asthma. Chest 2002; 121:1401. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Condemi J J. Comparison of the efficacy of formoterol and salmeterol in patients with reversible obstructive airway disease. Clin Ther 2001; 23:1529. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Tattersfield A E, Lofdahl C G, Postma D S, Eivindson A, Schreurs A GM, Rasidakis A, Ekstrom T. Comparison of formoterol and terbutaline for as-needed treatment of asthma. Lancet 2001; 357:257. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Cazzola M, Di Perna F, D'Amato M, di Marco F, di Perna F, Carlucci P, Boveri B, Santus P. Formoterol turbuhaler for as-needed therapy in patients with mild exacerbations of COPD. Respir Med 2001; 95:917. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Malolepszy J, Boszormenyi N G, Selroos O, Larsso P, Brander R. Safety of formoterol turbuhaler at cimulative dose of 90 microg in patients with acute bronchial obstruction. Eur Respir J 2001; 18:928. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• McIvor R A, Pizzichini E, Turner M O, Hussack P, Hargreave F E, Sears M R. Potential masking effects of salmeterol on airway inflammation in asthma. Am J Respir Crit Care Med 1998; 158:924. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Li X, Ward C, Thien F, Bish R, Bamford T, Bao X, Bailey M, Wilson J W, Walters E H. An anti-inflammatory effect of salmeterol, a long-acting β2 agonist, assessed in airway biopsies and bronchoalveolar lavage in asthma. Am J Respir Crit Care Med 1999; 160:1493. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Calhoun W J, Hinton K L, Kratzenberg J J. The effect of salmeterol on markers of airway inflammation following segmental allergen challenge. Am J Respir Crit Care Med 2001; 163:881. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Roberts J A, Bradding P, Britten K M, Walls A F, Wilson S, Gratziou C, Holgate S T, Howarth P H. The long-acting β2-agonist salmeterol xinafoate: effects on airway inflammation in asthma. Eur Respir J 1999; 14:275. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Wallin A, Sandstrom T, Soderberg M, Howarth P, Lundback B, Cippa G D, Wilson S, Judd M, Djukanovic R, Holgate S, Lindberg A, Larssen L. The effects of regular inhaled formoterol, budesonide, and placebo on mucosal inflammation and clinical indices in mild asthma. Am J Respir Crit Care Med 1998; 158:79.
   Google Scholar
• Yates D H, Sussman H S, Shaw M J, Barnes P J, Chung K F. Regular formoterol treatment in mild asthma. Am J Respir Crit Care Med 1995; 152:1170. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Nelson H S, Berkowitz R B, Tinkelman D A, Emmett A H, Rickard D A, Yancey S W. Lack of subsensitivity to albuterol after treatment with salmeterol in patients with asthma. Am J Respir Crit Care Med 1999; 159:1556. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Korosec M, Novak R D, Myers E, Skowronski M, McFadden E R. Salmeterol does not compromise the bronchodilator response to albuterol during acute episodes of asthma. Am J Med 1999; 107:209. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Tan K S, Grove A, McLean A, Gnosspelius Y, Hall I P, Lipworth B. Systemic corticosteroid rapidly reverses bronchodilator subsensitivity induced by formoterol in asthmatic patients. Am J Respir Crit Care Med 1997; 156:26.
   Web of Science ®Google Scholar